|
This is an index of adverse event reports related to Premarin (Conjugated Estrogens). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (744)
Cases resulting in a serious event (741)
Cases resulting in death (34)
Cases resulting in life threatening events (5)
Cases resulting in hospitalization (132)
Cases resulting in disability (7)
Cases resulting in other serious reactions (706)
Below is a sample of adverse event reports reports related to Premarin (Conjugated Estrogens). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1982-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer, Lung Neoplasm Malignant, Myocardial Infarction, Cerebrovascular Accident
Suspect drug(s):
Estrogen NOS
Medroxyprogesterone Acetate
Premarin
Prempro
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Systemic Lupus Erythematosus
Suspect drug(s):
Medroxyprogesterone Acetate
Premarin
Prempro
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 57.7 kg (126.9 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Premarin
Prempro
Dosage: not specified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2001-01-01
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrogen NOS
Premarin
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1984-01-01
End date: 1997-04-01
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Climara
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female, weighing 79.5 kg (174.8 pounds)
Adverse reactions / side effects: Ovarian Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Estrace
Estradiol
Dosage: unknown
Administration route: Oral
Indication: Menopausal Symptoms Prophylaxis
Start date: 1989-01-01
Estrogens Esterified / Methyltestosterone
Premarin
Dosage: unspecified
Administration route: Oral
Start date: 1992-01-01
End date: 2004-01-01
Other drugs received by patient: Xanax
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-31
Patient: female, weighing 74.9 kg (164.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Prempro
Dosage: unspecified daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2002-03-01
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Premarin
Prempro / Premphase
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: female
Adverse reactions / side effects: Endometrial Cancer Metastatic, Ovarian Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 48 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in 60 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 60 year old female, weighing 70.4 kg (154.8 pounds)
Adverse reactions / side effects: Pulmonary Embolism, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Suspect drug(s):
Cycrin
Dosage: unspecified, oral
Administration route: Oral
Start date: 1989-07-01
End date: 1999-07-01
Premarin
Dosage: unspecified, oral
Administration route: Oral
Start date: 1999-07-01
End date: 1999-07-01
Provera
Adverse event in 55 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 55 year old female, weighing 68.1 kg (149.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Medroxyprogesterone
Premarin
Adverse event in 54 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 54 year old female, weighing 737.8 kg (1623.1 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in 58 year old female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-10-30
Patient: 58 year old female, weighing 132.2 kg (290.8 pounds)
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin (Conjugated Estrogens)
Other drugs received by patient: Synthroid; Multivitamins, Plain (Multivitamins, Plain); Aspirin; Calcium (Calcium); Glucophage; Neurontin; Allegra-D (Fexofenadine Hydrochloride / Pseudoephedrine Hydrochloride); Advair Diskus 100 / 50; Cymbalta
Adverse event in 50 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 50 year old female, weighing 93.5 kg (205.7 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Ovarian Cancer Metastatic, Endometrial Cancer Metastatic
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Premarin (Conjugated Estrogens)
Adverse event in 65 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 65 year old female
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Premarin
Provera
|
